tetano
Editor, Senior Moderator
J Trop Pediatr
. 2020 Dec 5;fmaa106.
doi: 10.1093/tropej/fmaa106. Online ahead of print.
Paediatric COVID-19: Milder Presentation-A Silver Lining in Dark Cloud
Sharmila Ramteke[SUP] 1 [/SUP], Rajesh Tikkas[SUP] 1 [/SUP], Manjusha Goel[SUP] 1 [/SUP], Shipra Mandraha[SUP] 1 [/SUP], Jyotsna Shrivastava[SUP] 1 [/SUP]
Affiliations
Abstract
Objective: To assess the clinico-epidemiological profile of paediatric patients with Corona virus disease 2019 (COVID-19) infection during the pandemic.
Methods: Clinico-epidemiological and laboratory profile of children between 1 month and 14 years were studied between 15 May and 31 July 2020, who had positive nasopharyngeal and oropharyngeal swab for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by reverse transcriptase-polymerase chain reaction (RT-PCR).
Results: A total of 30 children with median age of 10.5 years (8 months to 14 years) were included in the present study. Sixty percent were boys. Twenty-seven (90%) belonged to an urban area and all 30 children were from a containment area. All were belonging to Kuppuswamy upper lower and lower socioeconomic class. Twenty-one (70%) were asymptomatic. All children had a positive household contact. Symptomatic children had only mild symptoms of fever, dry cough and rhinitis. All were fully vaccinated as per age. Nine (30%) had anaemia. The mean leucocyte count was 7470 ? 2427 (4300-14 100). Leucocytosis was seen in 3 (9%) children. C-reactive protein was found to be raised in only 4 (13%) children. We did not find alteration in sense of smell and taste. No mortality was reported.
Conclusion: COVID-19 in paediatric patients is usually mild. Severe acute respiratory infection is not a major manifestation of COVID 19 infection in children. All children infected by the novel Corona virus-2 in this study, have a documented household contact.
Keywords: COVID 19; SARS-CoV-2; children; clinico-epidemiological profile.
. 2020 Dec 5;fmaa106.
doi: 10.1093/tropej/fmaa106. Online ahead of print.
Paediatric COVID-19: Milder Presentation-A Silver Lining in Dark Cloud
Sharmila Ramteke[SUP] 1 [/SUP], Rajesh Tikkas[SUP] 1 [/SUP], Manjusha Goel[SUP] 1 [/SUP], Shipra Mandraha[SUP] 1 [/SUP], Jyotsna Shrivastava[SUP] 1 [/SUP]
Affiliations
- PMID: 33280024
- DOI: 10.1093/tropej/fmaa106
Abstract
Objective: To assess the clinico-epidemiological profile of paediatric patients with Corona virus disease 2019 (COVID-19) infection during the pandemic.
Methods: Clinico-epidemiological and laboratory profile of children between 1 month and 14 years were studied between 15 May and 31 July 2020, who had positive nasopharyngeal and oropharyngeal swab for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by reverse transcriptase-polymerase chain reaction (RT-PCR).
Results: A total of 30 children with median age of 10.5 years (8 months to 14 years) were included in the present study. Sixty percent were boys. Twenty-seven (90%) belonged to an urban area and all 30 children were from a containment area. All were belonging to Kuppuswamy upper lower and lower socioeconomic class. Twenty-one (70%) were asymptomatic. All children had a positive household contact. Symptomatic children had only mild symptoms of fever, dry cough and rhinitis. All were fully vaccinated as per age. Nine (30%) had anaemia. The mean leucocyte count was 7470 ? 2427 (4300-14 100). Leucocytosis was seen in 3 (9%) children. C-reactive protein was found to be raised in only 4 (13%) children. We did not find alteration in sense of smell and taste. No mortality was reported.
Conclusion: COVID-19 in paediatric patients is usually mild. Severe acute respiratory infection is not a major manifestation of COVID 19 infection in children. All children infected by the novel Corona virus-2 in this study, have a documented household contact.
Keywords: COVID 19; SARS-CoV-2; children; clinico-epidemiological profile.